These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 22624449)

  • 1. The Dead Sea and SCHF patients with an ICD.
    Harari M; Abu-Sirhan L
    Isr Med Assoc J; 2012 Jan; 14(1):73; author reply 73. PubMed ID: 22624449
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of descent and stay at a Dead Sea resort (low altitude) on patients with systolic congestive heart failure and an implantable cardioverter defibrillator.
    Gabizon I; Shiyovich A; Novack V; Khalameizer V; Yosefy C; Moses SW; Katz A
    Isr Med Assoc J; 2011 Jul; 13(7):402-7. PubMed ID: 21838181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Dead Sea: good for the soul, good for the heart.
    Schliamser JE; Amir O
    Isr Med Assoc J; 2011 Jul; 13(7):438-9. PubMed ID: 21838189
    [No Abstract]   [Full Text] [Related]  

  • 4. Characterization and predictors of first and subsequent inappropriate ICD therapy by heart rate ranges: Result of the MADIT-RIT efficacy analysis.
    Kutyifa V; Daubert JP; Olshansky B; Huang DT; Zhang C; Ruwald AC; McNitt S; Zareba W; Moss AJ; Schuger C
    Heart Rhythm; 2015 Sep; 12(9):2030-7. PubMed ID: 26001510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remote monitoring reduces healthcare use and improves quality of care in heart failure patients with implantable defibrillators: the evolution of management strategies of heart failure patients with implantable defibrillators (EVOLVO) study.
    Landolina M; Perego GB; Lunati M; Curnis A; Guenzati G; Vicentini A; Parati G; Borghi G; Zanaboni P; Valsecchi S; Marzegalli M
    Circulation; 2012 Jun; 125(24):2985-92. PubMed ID: 22626743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationale, design, and baseline characteristics of the DANish randomized, controlled, multicenter study to assess the efficacy of Implantable cardioverter defibrillators in patients with non-ischemic Systolic Heart failure on mortality (DANISH).
    Thune JJ; Pehrson S; Nielsen JC; Haarbo J; Videbæk L; Korup E; Jensen G; Hildebrandt P; Steffensen FH; Bruun NE; Eiskjær H; Brandes A; Thøgersen AM; Egstrup K; Hastrup-Svendsen J; Høfsten DE; Torp-Pedersen C; Køber L
    Am Heart J; 2016 Sep; 179():136-41. PubMed ID: 27595688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ventricular rate monitoring as a tool to predict and prevent atrial fibrillation-related inappropriate shocks in heart failure patients treated with cardiac resynchronisation therapy defibrillators.
    Ricci RP; Pignalberi C; Landolina M; Santini M; Lunati M; Boriani G; Proclemer A; Facchin D; Catanzariti D; Morani G; Gulizia M; Mangoni L; Grammatico A; Gasparini M;
    Heart; 2014 Jun; 100(11):848-54. PubMed ID: 24682569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical therapy versus implantable cardioverter -defibrillator in preventing sudden cardiac death in patients with left ventricular systolic dysfunction and heart failure: a meta-analysis of > 35,000 patients.
    Peck KY; Lim YZ; Hopper I; Krum H
    Int J Cardiol; 2014 May; 173(2):197-203. PubMed ID: 24636548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implantable cardioverter defibrillators and quality of life: results from the defibrillators in nonischemic cardiomyopathy treatment evaluation study.
    Passman R; Subacius H; Ruo B; Schaechter A; Howard A; Sears SF; Kadish A
    Arch Intern Med; 2007 Nov; 167(20):2226-32. PubMed ID: 17998496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of implantation of a subcutaneous implantable cardioverter-defibrillator in a patient with complete heart block and a pacemaker.
    Porterfield C; DiMarco JP; Mason PK
    Am J Cardiol; 2015 Jan; 115(2):276-8. PubMed ID: 25465940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How to select patients who will not benefit from ICD therapy by using heart rate and its variability?
    Sacha J; Barabach S; Statkiewicz-Barabach G; Sacha K; Müller A; Piskorski J; Barthel P; Schmidt G
    Int J Cardiol; 2013 Sep; 168(2):1655-8. PubMed ID: 23578894
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of ICD implantation on quality-adjusted life years in patients with congestive heart failure.
    Ozasa N; Morimoto T; Furukawa Y; Shizuta S; Nishiyama K; Kita T; Kimura T
    Int J Cardiol; 2008 Jan; 123(2):213-6. PubMed ID: 17367883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anesthesia care for subcutaneous implantable cardioverter/defibrillator placement: a single-center experience.
    Essandoh MK; Portillo JG; Weiss R; Otey AJ; Zuleta-Alarcon AN; Humeidan ML; Torres JL; Flores AS; Castellon-Larios K; Abdel-Rasoul M; Andritsos MJ; Perez WJ; Stein EJ; Turner KR; Dimitrova GT; Awad H; Bhandary SP; Tripathi RS; Joseph NC; Hummel JD; Augostini RS; Kalbfleisch SJ; Tyler JD; Houmsse M; Daoud EG
    J Clin Anesth; 2016 Jun; 31():53-9. PubMed ID: 27185678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-study.
    De Marco T; Wolfel E; Feldman AM; Lowes B; Higginbotham MB; Ghali JK; Wagoner L; Kirlin PC; Kennett JD; Goel S; Saxon LA; Boehmer JP; Mann D; Galle E; Ecklund F; Yong P; Bristow MR
    J Card Fail; 2008 Feb; 14(1):9-18. PubMed ID: 18226768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of implantable cardioverter-defibrillators.
    Sanders GD; Hlatky MA; Owens DK
    N Engl J Med; 2005 Oct; 353(14):1471-80. PubMed ID: 16207849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implantable device use in systolic heart failure: lessons learned from IMPROVE HF.
    Quin EM; Gold MR
    Heart Rhythm; 2009 Dec; 6(12):1735-6. PubMed ID: 19959120
    [No Abstract]   [Full Text] [Related]  

  • 17. Three-dimensional heart rate variability diagnostic for monitoring heart failure through an implantable device.
    Carlson G; Girouard S; Schlegl M; Butter C
    J Cardiovasc Electrophysiol; 2004 Apr; 15(4):506. PubMed ID: 15090004
    [No Abstract]   [Full Text] [Related]  

  • 18. SCD-HeFT: Use of R-R interval statistics for long-term risk stratification for arrhythmic sudden cardiac death.
    Au-Yeung WT; Reinhall PG; Poole JE; Anderson J; Johnson G; Fletcher RD; Moore HJ; Mark DB; Lee KL; Bardy GH
    Heart Rhythm; 2015 Oct; 12(10):2058-66. PubMed ID: 26096609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Letter by Fazio and Carlomagno regarding article, "Heart rate predicts outcomes in an implantable cardioverter-defibrillator population".
    Fazio S; Carlomagno G
    Circulation; 2010 Jun; 121(24):e451; author reply e452. PubMed ID: 20566963
    [No Abstract]   [Full Text] [Related]  

  • 20. Inappropriate shock for myopotential over-sensing in a patient with subcutaneous ICD.
    Corzani A; Ziacchi M; Biffi M; Diemberger I; Martignani C; Boriani G
    Indian Heart J; 2015; 67(1):56-9. PubMed ID: 25820052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.